Issue: Alleged unlawful off-label marketing

United States ex rel. Matthew Cestra v. Cephalon, No. 14-01842 (E.D. Pa.); United States ex rel. Bruce Boise, et al. v. Cephalon, No. 08-287 (E.D. Pa.)

Lieff Cabraser, with co-counsel, represented four whistleblowers bringing claims on behalf of the U.S. Government and various states against Cephalon, Inc., a pharmaceutical company.

Relators alleged that Cephalon engaged in improper or off-label marketing of a cancer drug and two wakefulness drugs. Motions to dismiss were denied in large part and the cases proceeded to discovery before resolving via settlement in 2017.

Case Resources

June 3, 2015
Memorandum
U.S. District Court

April 15, 2015
Memorandum
U.S. District Court